This trial assesses the suitability of HealthBeacon ICMS for respiratory patients, to help them manage their medications at home and increase adherence.
- Respiratory Diseases
1 Primary · 3 Secondary · Reporting Duration: 1 year
Awards & Highlights
1 Treatment Group
HealthBeacon Injection Care Management System (ICMS) Arm
1 of 1
10 Total Participants · 1 Treatment Group
Primary Treatment: HealthBeacon Injection Care Management System (ICMS) Arm · No Placebo Group · N/A
Who is running the clinical trial?
Age 18+ · All Participants · 1 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Is there space available for participants in this trial?
"Affirmative. Clinicaltrials.gov presents evidence that this experiment is actively seeking volunteers, having first been posted on November 1st 2022 and last updated 28 days later. A total of 10 candidates are needed at a single study site." - Anonymous Online Contributor
To what extent is this study recruiting participants?
"Affirmative. On clinicaltrials.gov, the information points to this trial's active recruitment of participants starting from November 1st 2022 and ending on November 28th 2022; 10 individuals are being sought after at a single medical center." - Anonymous Online Contributor